Core Cap Advisors, LLC Tekla Life Sciences Investors Transaction History
Core Cap Advisors, LLC
- $2.07 Billion
- Q3 2024
A detailed history of Core Cap Advisors, LLC transactions in Tekla Life Sciences Investors stock. As of the latest transaction made, Core Cap Advisors, LLC holds 884 shares of HQL stock, worth $12,641. This represents 0.0% of its overall portfolio holdings.
Number of Shares
884
Previous 884
-0.0%
Holding current value
$12,641
Previous $12,000
8.33%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding HQL
# of Institutions
75Shares Held
9.29MCall Options Held
0Put Options Held
0-
Saba Capital Management, L.P. New York, NY3.43MShares$49 Million1.1% of portfolio
-
Penserra Capital Management LLC Orinda, CA776KShares$11.1 Million0.25% of portfolio
-
Morgan Stanley New York, NY490KShares$7 Million0.0% of portfolio
-
Karpus Management, Inc. Pittsford, NY469KShares$6.7 Million0.23% of portfolio
-
Sit Investment Associates Inc Minneapolis, MN417KShares$5.96 Million0.14% of portfolio
About TEKLA LIFE SCIENCES INVESTORS
- Ticker HQL
- Exchange NYSE
- Sector Financial Services
- Industry Asset Management
- Description
- Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...